Beaupre, L.
,
Sobolev, B.
Guy, P.
Kim, J. D.
Kuramoto, L.
Sheehan, K. J.
Sutherland, J. M.
Harvey, E.
Morin, S. N.
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 133629)
Article History
Received: 1 August 2018
Accepted: 15 March 2019
First Online: 1 April 2019
Compliance with ethical standards
:
: The following competing interests are declared: (1) LB is the David Magee Endowed Chair in Musculoskeletal Research supported by the Faculty of Rehabilitation Medicine at the University of Alberta. (2) PG has received grants from the Canadian Institutes of Health Research related to this work. PG also receives funding from the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, and the British Columbia Specialists Services Committee for work around hip fracture care not related to this manuscript. He has also received fees from the BC Specialists Services Committee (for a provincial quality improvement project on redesign of hip fracture care) and from Stryker Orthopedics (as a product development consultant). He is a board member and shareholder in Traumis Surgical Systems Inc. and a board member for the Canadian Orthopedic Foundation. He also serves on the speakers’ bureaus of AO Trauma North America and Stryker Canada. (3) SNM reports research grants from Amgen Canada and from Merck. (4) BS, JDK, LK, KJS, JMS, and EH declare they have no conflicts of interest.